| Nov 7 |
Returns At Cogstate (ASX:CGS) Are On The Way Up
|
| Oct 29 |
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
|
| Oct 22 |
Uncovering Opportunities: Acusensus And 2 Other ASX Penny Stocks
|
| Oct 16 |
Cogstate Insider Ups Holding During Year
|
| Oct 14 |
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
|
| Oct 9 |
Cogstate Ltd (COGZF) Full Year 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges
|
| Sep 30 |
Investors in Cogstate (ASX:CGS) have seen enviable returns of 326% over the past five years
|
| Aug 27 |
Cogstate Full Year 2024 Earnings: EPS Beats Expectations
|
| Aug 12 |
Actinogen Medical stocks plummet after Phase IIa depression trial failure
|
| Jul 26 |
Cogstate Limited's (ASX:CGS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
|
